BridgeBio: Next Chapter Begins After Attruby Approval
2025 will be a very eventful year for BridgeBio. In addition to the commercial launches of Attruby in the United States, ...
devdiscourse2h
BridgeBio's Breakthrough in Rare Heart Condition Treatment
The U.S. FDA has approved Attruby, a new drug by BridgeBio, for treating a rare heart condition, redefining a market led by ...
BioSpace2h
FDA Action Alert: Applied Therapeutics Awaits Verdict on Rare Disease Therapy
With two decisions originally scheduled for this week already announced, including BridgeBio's approval in ATTR-CM, the ...
devdiscourse7h
FDA Highlights and Health Concerns: From Heart Drugs to Mpox Updates
This summary of health news features the FDA's approval of BridgeBio's heart drug, studies on cancer indicators in healthy ...
Indiatimes7h
India News
During an address to the Bihari diaspora in the US, political strategist Prashant Kishor characterized Bihar as a "failed state," drawing parallels to Sudan and emphasizing the state's dire need ...